A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
Clinical trial NCT06821542 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06821542
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-04
- Primary completion
- 2028-05-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.